AAAAAA
Results:
1-13
|
Results: 13
Authors:
Miles, DW
Smith, IE
Coleman, RE
Calvert, AH
Lind, MJ
Citation: Dw. Miles et al., A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancer, EUR J CANC, 37(11), 2001, pp. 1366-1371
Authors:
Plunkett, TA
Hanby, AM
Miles, DW
Rubens, RD
Citation: Ta. Plunkett et al., Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere) chemotherapy, ANN ONCOL, 12(3), 2001, pp. 411-414
Authors:
Gillett, CE
Miles, DW
Ryder, K
Skilton, D
Liebman, RD
Springall, RJ
Barnes, DM
Hanby, AM
Citation: Ce. Gillett et al., Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast, J PATHOLOGY, 193(4), 2001, pp. 433-441
Authors:
Coleman, RE
Howell, A
Eggleton, SPH
Maling, SJ
Miles, DW
Citation: Re. Coleman et al., Phase II study of docetaxel in patients with liver metastases from breast cancer, ANN ONCOL, 11(5), 2000, pp. 541-546
Authors:
Barnes, DM
Miles, DW
Citation: Dm. Barnes et Dw. Miles, Response of metastatic breast cancer to trastuzumab?, LANCET, 355(9199), 2000, pp. 160-161
Authors:
Dowsett, M
Pfister, C
Johnston, SRD
Miles, DW
Houston, SJ
Verbeek, JA
Gundacker, H
Sioufi, A
Smith, IE
Citation: M. Dowsett et al., Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer, CLIN CANC R, 5(9), 1999, pp. 2338-2343
Authors:
Miles, DW
Ross, T
Citation: Dw. Miles et T. Ross, Identifying and quantifying risks in the food production chain, FOOD AUST, 51(7), 1999, pp. 298-303
Authors:
Taylor-Papadimitriou, J
Burchell, J
Miles, DW
Dalziel, M
Citation: J. Taylor-papadimitriou et al., MUC1 and cancer, BBA-MOL BAS, 1455(2-3), 1999, pp. 301-313
Authors:
Plunkett, TA
Miles, DW
Citation: Ta. Plunkett et Dw. Miles, Immunotherapy: the last 25 years, CANC TR REV, 25(6), 1999, pp. 355-363
Authors:
Miles, DW
Taylor-Papadimitriou, J
Citation: Dw. Miles et J. Taylor-papadimitriou, Therapeutic aspects of polymorphic epithelial mucin in adenocarcinoma, PHARM THERA, 82(1), 1999, pp. 97-106
Authors:
Miles, DW
Harris, WH
Gillett, CE
Smith, P
Barnes, DM
Citation: Dw. Miles et al., Effect of c-erbB(2) and estrogen receptor status on survival of women withprimary breast cancer treated with adjuvant cyclophosphamide/methotrexate/fluorouracil, INT J CANC, 84(4), 1999, pp. 354-359
Authors:
Nath, D
Hartnell, A
Happerfield, L
Miles, DW
Burchell, J
Taylor-Papadimitriou, J
Crocker, PR
Citation: D. Nath et al., Macrophage-tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter-receptor for the macrophage-restricted receptor, sialoadhesin, IMMUNOLOGY, 98(2), 1999, pp. 213-219
Authors:
Houston, SJ
Plunkett, TA
Barnes, DM
Smith, P
Rubens, RD
Miles, DW
Citation: Sj. Houston et al., Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer, BR J CANC, 79(7-8), 1999, pp. 1220-1226
Risultati:
1-13
|